Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Xoma Corp (XOMA)

Xoma Corp (XOMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Xoma Corp 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 USA

www.xoma.com P: 510-204-7200

Description:

XOMA Corporation is a biopharmaceutical company engaged in the discovery, development, and manufacturing of therapeutic antibodies to treat autoimmune, infectious, inflammatory, and oncological diseases. The company's flagship product is gevokizumab, a humanized antibody to interleukin-1' with potential for the treatment of the inflammatory cause of multiple diseases. XOMA Corporation, formally known as XOMA Ltd., is headquartered in Berkeley, California.

Key Statistics

Overview:

Market Capitalization, $K 291,091
Enterprise Value, $K 261,751
Shares Outstanding, K 11,639
Annual Sales, $ 4,760 K
Annual Net Income, $ -40,830 K
Last Quarter Sales, $ 1,490 K
Last Quarter Net Income, $ -8,600 K
EBIT, $ -38,000 K
EBITDA, $ -37,100 K
60-Month Beta 0.85
% of Insider Shareholders 7.20%
% of Institutional Shareholders 95.92%
Float, K 10,801
% Float 92.80%
Short Volume Ratio 0.31

Growth:

1-Year Return 44.23%
3-Year Return -17.76%
5-Year Return 50.39%
5-Year Revenue Growth -10.19%
5-Year Earnings Growth -67.30%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.86 on 05/09/24
Next Earnings Date 05/14/24
Earnings Per Share ttm -2.54
EPS Growth vs. Prev Qtr -75.51%
EPS Growth vs. Prev Year 12.24%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 10/18/16

XOMA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -26.00%
Return-on-Assets % -14.30%
Profit Margin % -857.77%
Debt/Equity 1.47
Price/Sales 58.71
Price/Cash Flow N/A
Price/Book 3.39
Book Value/Share 7.07
Interest Coverage -70.63
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar